MLH3 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 6.669400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
9.005600E-01
Normal-vs-Stage2
6.645000E-01
Normal-vs-Stage3
1.582240E-02
Normal-vs-Stage4
6.239400E-01
Stage1-vs-Stage2
4.288600E-01
Stage1-vs-Stage3
2.043800E-02
Stage1-vs-Stage4
5.866200E-01
Stage2-vs-Stage3
3.066100E-02
Stage2-vs-Stage4
1.300800E-01
Stage3-vs-Stage4
1.134050E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
6.993800E-01
Normal-vs-AfricanAmerican
6.050600E-01
Normal-vs-Asian
1.344440E-01
Caucasian-vs-AfricanAmerican
8.735200E-01
Caucasian-vs-Asian
9.842500E-02
AfricanAmerican-vs-Asian
2.647200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
7.185000E-01
Normal-vs-Female
6.059200E-01
Male-vs-Female
5.239400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
8.886400E-01
Normal-vs-Age(41-60Yrs)
9.588000E-01
Normal-vs-Age(61-80Yrs)
5.417000E-01
Normal-vs-Age(81-100Yrs)
5.698400E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
9.330800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
6.304400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
6.489800E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
4.481500E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
2.542400E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
9.335800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
3.613800E-01
Normal-vs-Daily Drinker
3.628400E-01
Normal-vs-Weekly Drinker
5.631600E-01
Normal-vs-Occasional Drinker
7.662000E-01
Normal-vs-Social Drinker
9.962200E-01
Non Drinker-vs-Daily Drinker
7.627200E-01
Non Drinker-vs-Weekly Drinker
9.204200E-01
Non Drinker-vs-Occasional Drinker
1.754350E-01
Non Drinker-vs-Social Drinker
1.089550E-01
Daily Drinker-vs-Weekly Drinker
7.677000E-01
Daily Drinker-vs-Occasional Drinker
1.500620E-01
Daily Drinker-vs-Social Drinker
1.072840E-01
Weekly Drinker-vs-Occasional Drinker
4.255000E-01
Weekly Drinker-vs-Social Drinker
3.001000E-01
Occasional Drinker-vs-Social Drinker
6.599800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
6.248400E-02
Normal-vs-Grade 2
2.944200E-02
Normal-vs-Grade 3
3.415700E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
9.296000E-01
Grade 1-vs-Grade 3
1.881170E-01
Grade 1-vs-Grade 4
6.248400E-02
Grade 2-vs-Grade 3
7.578200E-02
Grade 2-vs-Grade 4
2.944200E-02
Grade 3-vs-Grade 4
3.415700E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
2.620000E-01
Normal-vs-NonDiabetic
5.979400E-01
Diabetic-vs-NonDiabetic
5.627800E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
4.452000E-02
Normal-vs-NoPancreatitis
5.379400E-01
Pancreatitis-vs-NoPancreatitis
2.086200E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
6.458000E-01
Normal-vs-N1
7.079000E-01
N0-vs-N1
7.259200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
8.038000E-01
Normal-vs-TP53-NonMutant
9.981200E-01
TP53-Mutant-vs-TP53-NonMutant
4.116600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
